IP Library Granted Patent US 9,435,721
Granted Patent B2
US 9,435,721 · App. 14/713,241 · Granted Sep 6, 2016

Isolation and characterization of tumor cells using shear stress measurements

Inventors: Michael D. Henry (Iowa City, IA); J. Matthew Barnes (San Francisco, CA)
Assignee: University of Iowa Research Foundation
G01N1/40B01L3/50273B01L3/502715C12N5/0693G01N33/487G01N33/5026G01N33/5044G01N33/5091G01N33/574B01L2200/027B01L2200/0647B01L2400/0475C12N2521/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,435,721
App. No.
14/713,241
Granted
Sep 6, 2016
Kind
B2
Abstract

Methods for isolating viable cancer cells from a sample that comprises a mixture of cancerous cells and normal (non-cancerous) cells are provided. In the methods, a fluid preparation comprising a mixture of cancerous and normal cells is repeatedly exposed to fluid shear stresses, whereby the repeated exposure to the fluid shear stresses preferentially imparts fluid shear stress-resistance to the cancerous cells.

Claims (18)

1. A method for purifying a fluid sample comprising extracellular calcium and cells of a mammalian subject, the cells comprising viable normal cells, the method comprising:

applying an initial pulse of fluid shear stress to the sample in vitro, wherein the initial pulse of fluid shear stress is sufficient to induce a fluid shear stress resistance in viable cancerous cells present in the sample such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells; and

subsequently applying one or more additional pulses of fluid shear stress to the sample in vitro, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells such that the ratio of the viable cancerous cells to the viable normal cells is increased.

2. The method of claim 1 , wherein the cells of the mammalian subject comprise lung cells.

3. The method of claim 2 , wherein the mammalian subject is a human.

4. The method of claim 1 , wherein the fluid sample is an in vitro fluid preparation.

5. The method of claim 4 , wherein the in vitro fluid preparation is prepared from a solid tissue biopsy.

6. The method of claim 1 , wherein the cells of the mammalian subject comprise the viable cancerous cells in addition to the viable normal cells.

7. The method of claim 1 , wherein the viable cancerous cells are viable cancerous epithelial cells.

8. The method of claim 1 , wherein the ratio of the viable cancerous cells to the viable normal cells in the sample is at least doubled.

9. The method of claim 1 , wherein the percent viability for the viable cancerous cells is at least 40% and the percent viability for the viable normal cells is no greater than 20% substantially immediately following the application of the initial and additional pulses of fluid shear stress, wherein percent viability is determined as the percent viability relative to a control maintained without the application of shear stresses for the duration of the pulse applications.

10. The method of claim 1 , wherein the initial and additional pulses of fluid shear stress apply a fluid shear stress in the range from about 500 dyn/cm 2 to about 6500dyn/cm 2 .

11. The method of claim 1 , wherein the additional pulses apply a supra-physiologic level of fluid shear stress.

12. The method of claim 1 , wherein the steps of applying the initial pulse of fluid shear stress to the sample and applying one or more additional pulses of fluid shear stress to the sample comprise passing the sample through a conduit at a substantially constant flow rate.

13. The method of claim 1 , wherein the initial pulse and the one or more additional pulses each have a duration of no greater than about 20 msec.

14. The method of claim 1 , wherein at least two additional pulses of fluid shear stress are applied to the sample.

15. The method of claim 1 , further comprising subsequently measuring the concentration of the viable cancerous cells in the sample.

16. The method of claim 1 , further comprising subsequently conducting an assay on the sample, the assay providing a cancer diagnosis or a cancer prognosis for the mammalian subject.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 1, 2015
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036052/0375 →
Continuity (3)
Continuation 14006761
Provisional Application 61466983 · Mar 24, 2011
Related Publication 20150307848A1 · Oct 29, 2015